ASCP Meetings
NCDEU Meeting
The NCDEU meeting in 2010 will be the 50th Anniversary meeting of NCDEU, and promises to be a very special meeting. A stellar group from ASCP, NIMH, FDA, Academia, and Industry are presently planning the speakers and events. The dates are June 14-17, 2010, and the location is Boca Raton, Florida.
In recent years, the NCDEU focus has been expanded to address a number of timely issues relevant to clinical research in psychiatry, including the translation of research into practice, the importance of regulatory issues, and pharmacogenetics and other means to personalizing interventions. NCDEU is co-sponsored by ASCP and the National Institute of Mental Health.
A popular part of NCDEU over the years has been the New Investigator's Award Program, in which early career researchers compete to attend NCDEU and a special symposium, present a poster, and receive an award.
As more information becomes available on the 50th Annual NCDEU Meeting and the New Investigator Award Program, it will be placed on the NCDEU web site:
To see the 2009 New Investigator Award Program flyer, click HERE.
The top posters from the 2009 NCDEU meeting will soon be placed on the MedFair web site:
NCDEU 2009
Translating Mental Health Research into Practice: Accelerating the Pace
This year’s program will focus on new strategies and models to enhance the development, testing, and impact of new treatments on practice. The theme for the upcoming meeting is Translating Mental Health Research into Practice: Accelerating the Pace. Proposals for workshops, panels, individual research reports, posters, and late-breaking research news that address the meeting’s theme and topics of special interest will be given high priority. The meeting also continues to place a special emphasis on the presentation of information or a reanalysis of existing information that has not been presented or published in the past.
Topics of special interest are those that address:
·
How do we know when we are ready for effectiveness research?
·
What's the evidence that clinicians want?
·
What are the advances in pharmacogenetics, biomarkers, and other means towards personalizing interventions?
·
What are the next steps needed to increase efficiency in clinical trials research?
·
Are there novel statistical approaches that can increase the efficiency of the design and analysis of clinical trials?
·
How can we engage relevant federal organizations and stakeholder groups in clinical research?
·
What is the impact of public policy and health care regulation on treatment decision-making?
·
How might regulatory changes affect the future of drug development?
·
How can information technology be used most effectively to enhance the conduct of clinical trials and the dissemination of their results?